Related Articles
Molecular impacts of rapamycin-based drug combinations: Combining rapamycin with gemcitabine or imatinib mesylate (Gleevec) in a human leiomyosarcoma model
Gemcitabine resistance in a highly metastatic subpopulation of a pulmonary adenocarcinoma cell line resistant to gefitinib
The cytoprotective role of gemcitabine-induced autophagy associated with apoptosis inhibition in triple-negative MDA-MB-231 breast cancer cells
Co-treatment with gemcitabine and nab-paclitaxel exerts additive effects on pancreatic cancer cell death
Curative resection for leiomyosarcoma of the descending mesocolon with metachronous liver metastasis: A case report and literature review